Skip to main content
Erschienen in: Clinical and Translational Oncology 5/2018

12.10.2017 | Research Article

Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly

verfasst von: R. Clèries, A. Ameijide, R. Marcos-Gragera, L. Pareja, M. Carulla, M.-L. Vilardell, L. Esteban, M. Buxó, J.-A. Espinàs, A. Puigdefàbregas, J. Ribes, A. Izquierdo, J. Galceran, J. M. Borrás

Erschienen in: Clinical and Translational Oncology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Developing effective cancer control programmes requires information on the future cancer burden in an ageing population. In our study we predicted the burden of cancer in Catalonia from 2015 to 2025.

Methods

Bayesian age–period–cohort models were used to predict the burden of cancer from 2015 to 2025 using incidence data from the Girona and Tarragona cancer registries and cancer mortality data from the Catalan mortality registry. Using the Bashir–Estève method, we divided the net change in the number of cases between 2015 and 2025 into changes due to population size (S), cancer risk (R) and age (A) distribution.

Results

By 2025, there will be 21,743 new cancer cases in men (40% aged > 74 years) and 17,268 in women (37% aged > 74 years). More than 40% of the new cases will be diagnosed among population aged 74 and older in prostate, colorectal, lung, bladder, pancreatic and stomach cancers in men, and in colorectal, pancreatic and bladder cancers and leukaemia in women. During 2015–2025, the number of new diagnoses will increase by 5.5% in men (A + R + S = 18.1% − 13.3% + 0.7% = 5.5%) and 11.9% in women (A + R + S = 12.4% − 1.1% + 0.6% = 11.9%). Overall cancer mortality rates will continue to decrease during 2015–2025. Lung cancer will be the most lethal cancer among men (N = 2705) and women (N = 1174).

Conclusions

The increase in the number of cancer cases in Catalonia from 2015 to 2025 will mostly affect the elderly, prompting the need for increased collaboration between geriatricians and oncologists.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 1930;2015:1–5. doi:10.1038/bjc.2014.606. Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 1930;2015:1–5. doi:10.​1038/​bjc.​2014.​606.
3.
4.
Zurück zum Zitat Ribes J, Esteban L, Clèries R, Galceran J, Marcos-Gragera R, Gispert R, et al. Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models. Clin Transl Oncol. 2014;16:714–24. doi:10.1007/s12094-013-1140-z.CrossRefPubMed Ribes J, Esteban L, Clèries R, Galceran J, Marcos-Gragera R, Gispert R, et al. Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models. Clin Transl Oncol. 2014;16:714–24. doi:10.​1007/​s12094-013-1140-z.CrossRefPubMed
6.
Zurück zum Zitat Clèries R, Buxó M, Martínez JM, Espinàs JA, Dyba T, Borràs JM. Contribution of changes in demography and in the risk factors to the predicted pattern of cancer mortality among Spanish women by 2022. Cancer Epidemiol. 2016;40:113–8. doi:10.1016/j.canep.2015.12.002.CrossRefPubMed Clèries R, Buxó M, Martínez JM, Espinàs JA, Dyba T, Borràs JM. Contribution of changes in demography and in the risk factors to the predicted pattern of cancer mortality among Spanish women by 2022. Cancer Epidemiol. 2016;40:113–8. doi:10.​1016/​j.​canep.​2015.​12.​002.CrossRefPubMed
8.
Zurück zum Zitat Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM. Geriatric assessment predicts survival and competing mortality in elderly patients with early colorectal cancer: can it help in adjuvant therapy decision-making? Oncologist. 2017;22(8):934–43. doi:10.1634/theoncologist.2016-0462. Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM. Geriatric assessment predicts survival and competing mortality in elderly patients with early colorectal cancer: can it help in adjuvant therapy decision-making? Oncologist. 2017;22(8):934–43. doi:10.​1634/​theoncologist.​2016-0462.
10.
Zurück zum Zitat Clèries R, Ribes J, Buxo M, Ameijide A, Marcos-Gragera R, Galceran J, et al. Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas. Stat Med. 2012;31:978–87. doi:10.1002/sim.4463.CrossRefPubMed Clèries R, Ribes J, Buxo M, Ameijide A, Marcos-Gragera R, Galceran J, et al. Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas. Stat Med. 2012;31:978–87. doi:10.​1002/​sim.​4463.CrossRefPubMed
12.
13.
Zurück zum Zitat Bilal U, Fernández E, Beltran P, Navas-acien A, Bolumar F, Franco M. Validation of a method for reconstructing historical rates of smoking prevalence. Am J Epidemiol. 2014;179:15–9. doi:10.1093/aje/kwt224.CrossRefPubMed Bilal U, Fernández E, Beltran P, Navas-acien A, Bolumar F, Franco M. Validation of a method for reconstructing historical rates of smoking prevalence. Am J Epidemiol. 2014;179:15–9. doi:10.​1093/​aje/​kwt224.CrossRefPubMed
14.
Zurück zum Zitat Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;2015:1–8. doi:10.1093/annonc/mdv001. Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;2015:1–8. doi:10.​1093/​annonc/​mdv001.
15.
18.
Zurück zum Zitat Rossi PG, Vicentini M, Sacchettini C, Di Felice E, Caroli S, Ferrari F, et al. Impact of screening program on incidence of colorectal cancer: a cohort study in Italy. Am J Gastroenterol. 2015;110:1359–66. doi:10.1038/ajg.2015.240.CrossRef Rossi PG, Vicentini M, Sacchettini C, Di Felice E, Caroli S, Ferrari F, et al. Impact of screening program on incidence of colorectal cancer: a cohort study in Italy. Am J Gastroenterol. 2015;110:1359–66. doi:10.​1038/​ajg.​2015.​240.CrossRef
21.
Zurück zum Zitat Bilal U, Beltran P, Fernández E, Navas-Ancien A, Bolumar F, Franco M. Gender equality and smoking: a theory-driven approach to smoking gender differences in Spain. Tob Control. 2016;25:295–300. doi:10.1136/tobaccocontrol.CrossRefPubMed Bilal U, Beltran P, Fernández E, Navas-Ancien A, Bolumar F, Franco M. Gender equality and smoking: a theory-driven approach to smoking gender differences in Spain. Tob Control. 2016;25:295–300. doi:10.​1136/​tobaccocontrol.CrossRefPubMed
23.
Zurück zum Zitat Hashibe M, Brennan P, Chuang S-C, Boccia S, Castellsague X, Chen C, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomark Prev. 2009;18:541–50. doi:10.1158/1055-9965.EPI-08-0347.CrossRef Hashibe M, Brennan P, Chuang S-C, Boccia S, Castellsague X, Chen C, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomark Prev. 2009;18:541–50. doi:10.​1158/​1055-9965.​EPI-08-0347.CrossRef
26.
Zurück zum Zitat Murta-nascimento C, Schmitz-Dräger BJ, Zeegers J, Schmitz-dräger MP, Steineck G, Kogevinas M, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’ s death. World J Urol. 2007;25:285–95. doi:10.1007/s00345-007-0168-5.CrossRefPubMed Murta-nascimento C, Schmitz-Dräger BJ, Zeegers J, Schmitz-dräger MP, Steineck G, Kogevinas M, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’ s death. World J Urol. 2007;25:285–95. doi:10.​1007/​s00345-007-0168-5.CrossRefPubMed
27.
Zurück zum Zitat Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case–Control Consortium (Panc4). Ann Oncol. 2012;23:1880–8. doi:10.1093/annonc/mdr541.CrossRefPubMed Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case–Control Consortium (Panc4). Ann Oncol. 2012;23:1880–8. doi:10.​1093/​annonc/​mdr541.CrossRefPubMed
28.
Zurück zum Zitat Marcos-Gragera R, Pollán M, Chirlaque MD, Gumà J, Sanchez MJ, Garau I, et al. Attenuation of the epidemic increase in non-Hodgkin’s lymphomas in Spain. Ann Oncol 2010; 21. doi:10.1093/annonc/mdq088. Marcos-Gragera R, Pollán M, Chirlaque MD, Gumà J, Sanchez MJ, Garau I, et al. Attenuation of the epidemic increase in non-Hodgkin’s lymphomas in Spain. Ann Oncol 2010; 21. doi:10.​1093/​annonc/​mdq088.
29.
30.
Metadaten
Titel
Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly
verfasst von
R. Clèries
A. Ameijide
R. Marcos-Gragera
L. Pareja
M. Carulla
M.-L. Vilardell
L. Esteban
M. Buxó
J.-A. Espinàs
A. Puigdefàbregas
J. Ribes
A. Izquierdo
J. Galceran
J. M. Borrás
Publikationsdatum
12.10.2017
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 5/2018
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-017-1764-5

Weitere Artikel der Ausgabe 5/2018

Clinical and Translational Oncology 5/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.